Sign In

Login

Password

Forgot Password ? Sign Up

Revmatoidní artritida (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Revmatoidní artritida" in Czech language version.

refsWebsite
Global rank Czech rank
61doi.org
2nd place
4th place
60worldcat.org
5th place
3rd place
25wiley.com
222nd place
83rd place
20nih.gov
4th place
8th place
13bmj.com
1,226th place
800th place
3oup.com
485th place
155th place
3jimmunol.org
low place
5,054th place
3elsevier.com
610th place
203rd place
2springer.com
274th place
174th place
2nature.com
234th place
72nd place
2web.archive.org
1st place
1st place
2sciencedirect.com
149th place
80th place
1interna-cz.eu
low place
low place
1proquest.com
206th place
2,611th place
1medicalxpress.com
8,255th place
77th place
1smj.org.sa
low place
low place
1ajhp.org
low place
low place
1tandfonline.com
507th place
215th place
1sciencemag.org
857th place
315th place

ajhp.org

bmj.com

ard.bmj.com

  • KÄLLBERG, Henrik; DING, Bo; PADYUKOV, Leonid. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Annals of the Rheumatic Diseases. 2011-03-01, roč. 70, čís. 3, s. 508–511. PMID: 21149499. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/ard.2009.120899. PMID 21149499. (anglicky) 
  • LU, Bing; HIRAKI, Linda T.; SPARKS, Jeffrey A. Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study. Annals of the Rheumatic Diseases. 2014-11-01, roč. 73, čís. 11, s. 1914–1922. PMID: 25057178. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2014-205459. PMID 25057178. (anglicky) 
  • STOLT, Patrik; YAHYA, Abqariyah; BENGTSSON, Camilla. Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis. Annals of the Rheumatic Diseases. 2010-06-01, roč. 69, čís. 6, s. 1072–1076. PMID: 19966090. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/ard.2009.114694. PMID 19966090. (anglicky) 
  • MIRIOVSKY, Benjamin J.; MICHAUD, Kaleb; THIELE, Geoffrey M. Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis. Annals of the Rheumatic Diseases. 2010-07-01, roč. 69, čís. 7, s. 1292–1297. PMID: 20439294. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/ard.2009.122739. PMID 20439294. (anglicky) 
  • BÖHLER, Christoph; RADNER, Helga; SMOLEN, Josef S. Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritis. Annals of the Rheumatic Diseases. 2013-02-01, roč. 72, čís. 2, s. 241–244. PMID: 23087181. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2012-202297. PMID 23087181. (anglicky) 
  • NELL, V. P. K.; MACHOLD, K. P.; STAMM, T. A. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Annals of the Rheumatic Diseases. 2005-12-01, roč. 64, čís. 12, s. 1731–1736. PMID: 15878904. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/ard.2005.035691. PMID 15878904. (anglicky) 
  • SMOLEN, Josef S.; LANDEWÉ, Robert; BIJLSMA, Johannes. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the Rheumatic Diseases. 2017-06-01, roč. 76, čís. 6, s. 960–977. PMID: 28264816. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2016-210715. PMID 28264816. (anglicky) 
  • SMOLEN, Josef S.; HEIJDE, Désirée van der; MACHOLD, Klaus P. Proposal for a new nomenclature of disease-modifying antirheumatic drugs. Annals of the Rheumatic Diseases. 2014-01-01, roč. 73, čís. 1, s. 3–5. PMID: 24072562. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2013-204317. PMID 24072562. (anglicky) 
  • GENOVESE, Mark C.; FLEISCHMANN, Roy; FURST, Daniel. Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study. Annals of the Rheumatic Diseases. 2014-09-01, roč. 73, čís. 9, s. 1607–1615. PMID: 24641941. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2013-204760. PMID 24641941. (anglicky) 
  • BURMESTER, Gerd R.; MCINNES, Iain B.; KREMER, Joel. A randomised phase IIb study of mavrilimumab, a novel GM–CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis. Annals of the Rheumatic Diseases. 2017-06-01, roč. 76, čís. 6, s. 1020–1030. PMID: 28213566. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2016-210624. PMID 28213566. (anglicky) 
  • BEHRENS, Frank; TAK, Paul P.; ØSTERGAARD, Mikkel. MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial. Annals of the Rheumatic Diseases. 2015-06-01, roč. 74, čís. 6, s. 1058–1064. PMID: 24534756. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2013-204816. PMID 24534756. (anglicky) 

bmjopen.bmj.com

  • GHAWI, Husam; CROWSON, Cynthia S.; RAND-WEAVER, Jennifer. A novel measure of socioeconomic status using individual housing data to assess the association of SES with rheumatoid arthritis and its mortality: a population-based case–control study. BMJ Open. 2015-04-01, roč. 5, čís. 4, s. e006469. PMID: 25926142. Dostupné online [cit. 2018-02-10]. ISSN 2044-6055. DOI 10.1136/bmjopen-2014-006469. PMID 25926142. (anglicky) 

rmdopen.bmj.com

doi.org

dx.doi.org

  • NIELEN, Markus M. J.; VAN SCHAARDENBURG, Dirkjan; REESINK, Henk W. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis & Rheumatism. 2004-02-01, roč. 50, čís. 2, s. 380–386. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.20018. (anglicky) 
  • PUENTE, Antonio Del; KNOWLER, William C.; PETTITT, David J. The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study. Arthritis & Rheumatism. 1988-10-01, roč. 31, čís. 10, s. 1239–1244. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.1780311004. (anglicky) 
  • HOEK, J. van den; BOSHUIZEN, H. C.; ROORDA, L. D. Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study. Rheumatology International. 2017-04-01, roč. 37, čís. 4, s. 487–493. Dostupné online [cit. 2018-02-10]. ISSN 0172-8172. DOI 10.1007/s00296-016-3638-5. (anglicky) 
  • ZAMORA-LEGOFF, Jorge A.; KRAUSE, Megan L.; CROWSON, Cynthia S. Patterns of interstitial lung disease and mortality in rheumatoid arthritis. Rheumatology. 2017-03-01, roč. 56, čís. 3, s. 344–350. Dostupné online [cit. 2018-02-10]. ISSN 1462-0324. DOI 10.1093/rheumatology/kew391. (anglicky) 
  • AVIÑA-ZUBIETA, J. Antonio; CHOI, Hyon K.; SADATSAFAVI, Mohsen. Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis Care & Research. 2008-12-15, roč. 59, čís. 12, s. 1690–1697. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.24092. (anglicky) 
  • ZLATKOVIĆ-ŠVENDA, Mirjana I.; STOJANOVIĆ, Roksanda M.; ŠIPETIĆ-GRUJIČIĆ, Sandra B. Prevalence of rheumatoid arthritis in Serbia. Rheumatology International. 2014-05-01, roč. 34, čís. 5, s. 649–658. Dostupné online [cit. 2018-02-10]. ISSN 0172-8172. DOI 10.1007/s00296-013-2897-7. (anglicky) 
  • PINCUS, Theodore; CALLAHAN, Leigh F.; SALE, William G. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis & Rheumatism. 1984-08-01, roč. 27, čís. 8, s. 864–872. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.1780270805. (anglicky) 
  • SOKKA, Tuulikki; KAUTIAINEN, Hannu; PINCUS, Theodore. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA Study. Arthritis Research & Therapy. 2010-03-12, roč. 12, s. R42. Dostupné online [cit. 2018-02-10]. ISSN 1478-6354. DOI 10.1186/ar2951. 
  • OKADA, Yukinori; CONSORTIUM, the RACI; WU, Di. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014/02, roč. 506, čís. 7488, s. 376–381. Dostupné online [cit. 2018-02-10]. ISSN 1476-4687. DOI 10.1038/nature12873. (En) 
  • GREGERSEN, Peter K.; SILVER, Jack; WINCHESTER, Robert J. The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis & Rheumatism. 1987-11-01, roč. 30, čís. 11, s. 1205–1213. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.1780301102. (anglicky) 
  • HILL, Jonathan A.; SOUTHWOOD, Scott; SETTE, Alessandro. Cutting Edge: The Conversion of Arginine to Citrulline Allows for a High-Affinity Peptide Interaction with the Rheumatoid Arthritis-Associated HLA-DRB1*0401 MHC Class II Molecule. The Journal of Immunology. 2003-07-15, roč. 171, čís. 2, s. 538–541. PMID: 12847215. Dostupné online [cit. 2018-02-10]. ISSN 0022-1767. DOI 10.4049/jimmunol.171.2.538. PMID 12847215. (anglicky) 
  • REVIRON, Denis; PERDRIGER, Aleth; TOUSSIROT, Eric. Influence of shared epitope–negative HLA–DRB1 alleles on genetic susceptibility to rheumatoid arthritis. Arthritis & Rheumatism. 2001-03-01, roč. 44, čís. 3, s. 535–540. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/1529-0131(200103)44:3%3C535::aid-anr101%3E3.0.co;2-z. (anglicky) 
  • KÄLLBERG, Henrik; DING, Bo; PADYUKOV, Leonid. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Annals of the Rheumatic Diseases. 2011-03-01, roč. 70, čís. 3, s. 508–511. PMID: 21149499. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/ard.2009.120899. PMID 21149499. (anglicky) 
  • GHAWI, Husam; CROWSON, Cynthia S.; RAND-WEAVER, Jennifer. A novel measure of socioeconomic status using individual housing data to assess the association of SES with rheumatoid arthritis and its mortality: a population-based case–control study. BMJ Open. 2015-04-01, roč. 5, čís. 4, s. e006469. PMID: 25926142. Dostupné online [cit. 2018-02-10]. ISSN 2044-6055. DOI 10.1136/bmjopen-2014-006469. PMID 25926142. (anglicky) 
  • LU, Bing; HIRAKI, Linda T.; SPARKS, Jeffrey A. Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study. Annals of the Rheumatic Diseases. 2014-11-01, roč. 73, čís. 11, s. 1914–1922. PMID: 25057178. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2014-205459. PMID 25057178. (anglicky) 
  • STOLT, Patrik; YAHYA, Abqariyah; BENGTSSON, Camilla. Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis. Annals of the Rheumatic Diseases. 2010-06-01, roč. 69, čís. 6, s. 1072–1076. PMID: 19966090. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/ard.2009.114694. PMID 19966090. (anglicky) 
  • LU, Bing; SOLOMON, Daniel H.; COSTENBADER, Karen H. Alcohol Consumption and Risk of Incident Rheumatoid Arthritis in Women: A Prospective Study. Arthritis & Rheumatology. 2014-08-01, roč. 66, čís. 8, s. 1998–2005. Dostupné online [cit. 2018-02-10]. ISSN 2326-5205. DOI 10.1002/art.38634. (anglicky) 
  • MAXWELL, James R.; GOWERS, Isobel R.; MOORE, David J. Alcohol consumption is inversely associated with risk and severity of rheumatoid arthritis. Rheumatology. 2010-11-01, roč. 49, čís. 11, s. 2140–2146. Dostupné online [cit. 2018-02-10]. ISSN 1462-0324. DOI 10.1093/rheumatology/keq202. (anglicky) 
  • WEGNER, Natalia; WAIT, Robin; SROKA, Aneta. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: Implications for autoimmunity in rheumatoid arthritis. Arthritis & Rheumatism. 2010-09-01, roč. 62, čís. 9, s. 2662–2672. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.27552. (anglicky) 
  • SCHER, Jose U.; LITTMAN, Dan R.; ABRAMSON, Steven B. Review: Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases. Arthritis & Rheumatology. 2016-01-01, roč. 68, čís. 1, s. 35–45. Dostupné online [cit. 2018-02-10]. ISSN 2326-5205. DOI 10.1002/art.39259. (anglicky) 
  • BROWN, Philip M.; ISAACS, John D. Rheumatoid arthritis: from palliation to remission in two decades. Clinical Medicine. 2014-12-01, roč. 14, čís. Suppl 6, s. s50–s55. PMID: 25468920. Dostupné v archivu pořízeném dne 2018-06-10. ISSN 1470-2118. DOI 10.7861/clinmedicine.14-6-s50. PMID 25468920. (anglicky)  Archivováno 10. 6. 2018 na Wayback Machine.
  • KIRKHAM, Bruce W.; LASSERE, Marissa N.; EDMONDS, John P. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: A two-year prospective study (the DAMAGE study cohort). Arthritis & Rheumatism. 2006-04-01, roč. 54, čís. 4, s. 1122–1131. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.21749. (anglicky) 
  • VAN HAMBURG, J. P.; ASMAWIDJAJA, P. S.; DAVELAAR, N. Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis & Rheumatism. 2011-01-01, roč. 63, čís. 1, s. 73–83. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.30093. (anglicky) 
  • WRIGHT, Helen L.; MOOTS, Robert J.; EDWARDS, Steven W. The multifactorial role of neutrophils in rheumatoid arthritis. Nature Reviews Rheumatology. 2014/10, roč. 10, čís. 10, s. 593–601. Dostupné online [cit. 2018-02-10]. ISSN 1759-4804. DOI 10.1038/nrrheum.2014.80. (En) 
  • ZHAO, Xiaoyan; OKEKE, Nwora Lance; SHARPE, Orr. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Research & Therapy. 2008-08-18, roč. 10, s. R94. Dostupné online [cit. 2018-02-10]. ISSN 1478-6354. DOI 10.1186/ar2478. 
  • MIRIOVSKY, Benjamin J.; MICHAUD, Kaleb; THIELE, Geoffrey M. Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis. Annals of the Rheumatic Diseases. 2010-07-01, roč. 69, čís. 7, s. 1292–1297. PMID: 20439294. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/ard.2009.122739. PMID 20439294. (anglicky) 
  • BÖHLER, Christoph; RADNER, Helga; SMOLEN, Josef S. Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritis. Annals of the Rheumatic Diseases. 2013-02-01, roč. 72, čís. 2, s. 241–244. PMID: 23087181. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2012-202297. PMID 23087181. (anglicky) 
  • KROOT, Eric-Jan J. A.; DE JONG, Ben A. W.; VAN LEEUWEN, Miek A. The prognostic value of anti–cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis & Rheumatism. 2000-08-01, roč. 43, čís. 8, s. 1831–1835. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/1529-0131(200008)43:8%3C1831::aid-anr19%3E3.0.co;2-6. (anglicky) 
  • NELL, V. P. K.; MACHOLD, K. P.; EBERL, G. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology. 2004-07-01, roč. 43, čís. 7, s. 906–914. Dostupné online [cit. 2018-02-10]. ISSN 1462-0324. DOI 10.1093/rheumatology/keh199. (anglicky) 
  • NELL, V. P. K.; MACHOLD, K. P.; STAMM, T. A. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Annals of the Rheumatic Diseases. 2005-12-01, roč. 64, čís. 12, s. 1731–1736. PMID: 15878904. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/ard.2005.035691. PMID 15878904. (anglicky) 
  • RANTAPÄÄ-DAHLQVIST, Solbritt; DE JONG, Ben A. W.; BERGLIN, Ewa. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis & Rheumatism. 2003-10-01, roč. 48, čís. 10, s. 2741–2749. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.11223. (anglicky) 
  • ALETAHA, Daniel; NEOGI, Tuhina; SILMAN, Alan J. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis & Rheumatism. 2010-09-01, roč. 62, čís. 9, s. 2569–2581. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.27584. (anglicky) 
  • SMOLEN, Josef S.; LANDEWÉ, Robert; BIJLSMA, Johannes. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the Rheumatic Diseases. 2017-06-01, roč. 76, čís. 6, s. 960–977. PMID: 28264816. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2016-210715. PMID 28264816. (anglicky) 
  • VAN DER LINDEN, Michael P. M.; LE CESSIE, Saskia; RAZA, Karim. Long-term impact of delay in assessment of patients with early arthritis. Arthritis & Rheumatism. 2010-12-01, roč. 62, čís. 12, s. 3537–3546. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.27692. (anglicky) 
  • SMOLEN, Josef S.; HEIJDE, Désirée van der; MACHOLD, Klaus P. Proposal for a new nomenclature of disease-modifying antirheumatic drugs. Annals of the Rheumatic Diseases. 2014-01-01, roč. 73, čís. 1, s. 3–5. PMID: 24072562. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2013-204317. PMID 24072562. (anglicky) 
  • CHOI, Hyon K; HERNÁN, Miguel A; SEEGER, John D. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. The Lancet. Roč. 359, čís. 9313, s. 1173–1177. Dostupné online [cit. 2018-02-10]. DOI 10.1016/s0140-6736(02)08213-2. 
  • ANDERSON, Jaclyn; CAPLAN, Liron; YAZDANY, Jinoos. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care & Research. 2012-05-01, roč. 64, čís. 5, s. 640–647. Dostupné online [cit. 2018-02-10]. ISSN 2151-4658. DOI 10.1002/acr.21649. (anglicky) 
  • MAINI, Ravinder N.; BREEDVELD, Ferdinand C.; KALDEN, Joachim R. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis & Rheumatism. 1998-09-01, roč. 41, čís. 9, s. 1552–1563. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/1529-0131(199809)41:9%3C1552::aid-art5%3E3.0.co;2-w. (anglicky) 
  • THOMPSON, Cheryl A. FDA approves tocilizumab to treat rheumatoid arthritis. American Journal of Health-System Pharmacy. 2010-02-15, roč. 67, čís. 4, s. 254–254. PMID: 20133526. Dostupné online [cit. 2018-02-10]. ISSN 1079-2082. DOI 10.2146/news100012. PMID 20133526. (anglicky) 
  • BOYAPATI, Anita; MSIHID, Jérôme; FIORE, Stefano. Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY. Arthritis Research & Therapy. 2016-10-06, roč. 18, s. 225. Dostupné online [cit. 2018-02-10]. ISSN 1478-6362. DOI 10.1186/s13075-016-1132-9. 
  • BONELLI, M.; FERNER, E.; GÖSCHL, L. Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis. Arthritis & Rheumatism. 2013-03-01, roč. 65, čís. 3, s. 599–607. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.37787. (anglicky) 
  • KREMER, Joel M.; DOUGADOS, Maxime; EMERY, Paul. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial. Arthritis & Rheumatism. 2005-08-01, roč. 52, čís. 8, s. 2263–2271. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.21201. (anglicky) 
  • PATAKAS, Agapitos; JI, Rui-Ru; WEIR, William. Abatacept Inhibition of T Cell Priming in Mice by Induction of a Unique Transcriptional Profile That Reduces Their Ability to Activate Antigen-Presenting Cells. Arthritis & Rheumatology. 2016-03-01, roč. 68, čís. 3, s. 627–638. Dostupné online [cit. 2018-02-10]. ISSN 2326-5205. DOI 10.1002/art.39470. (anglicky) 
  • COHEN, Stanley B.; EMERY, Paul; GREENWALD, Maria W. Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis & Rheumatism. 2006-09-01, roč. 54, čís. 9, s. 2793–2806. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.22025. (anglicky) 
  • SKINGLE, Diana. Biosimilars: what do patients need to consider?. RMD Open. 2015-09-01, roč. 1, čís. 1, s. e000141. Dostupné online [cit. 2018-02-10]. ISSN 2056-5933. DOI 10.1136/rmdopen-2015-000141. (anglicky) 
  • FRIDMAN, Jordan S.; SCHERLE, Peggy A.; COLLINS, Robert. Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050. The Journal of Immunology. 2010-05-01, roč. 184, čís. 9, s. 5298–5307. PMID: 20363976. Dostupné online [cit. 2018-02-10]. ISSN 0022-1767. DOI 10.4049/jimmunol.0902819. PMID 20363976. (anglicky) 
  • PAPP, K.a.; MENTER, M.a.; RAMAN, M. A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis. British Journal of Dermatology. 2016-06-01, roč. 174, čís. 6, s. 1266–1276. Dostupné online [cit. 2018-02-10]. ISSN 1365-2133. DOI 10.1111/bjd.14403. (anglicky) 
  • CHANGELIAN, Paul S.; FLANAGAN, Mark E.; BALL, Douglas J. Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor. Science. 2003-10-31, roč. 302, čís. 5646, s. 875–878. PMID: 14593182. Dostupné online [cit. 2018-02-10]. ISSN 0036-8075. DOI 10.1126/science.1087061. PMID 14593182. (anglicky) 
  • Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial. The Lancet. 2015-08-08, roč. 386, čís. 9993, s. 552–561. Dostupné online [cit. 2018-02-10]. ISSN 0140-6736. DOI 10.1016/S0140-6736(14)62113-9. (anglicky) 
  • BUA, Silvia; DI CESARE MANNELLI, Lorenzo; VULLO, Daniela. Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs–CAIs) for the Treatment of Rheumatoid Arthritis. Journal of Medicinal Chemistry. 2017-02-09, roč. 60, čís. 3, s. 1159–1170. Dostupné online [cit. 2018-02-10]. ISSN 0022-2623. DOI 10.1021/acs.jmedchem.6b01607. 
  • GENOVESE, Mark C.; VAN VOLLENHOVEN, Ronald F.; PACHECO-TENA, César. VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis. Arthritis & Rheumatology. 2016-01-01, roč. 68, čís. 1, s. 46–55. Dostupné online [cit. 2018-02-10]. ISSN 2326-5205. DOI 10.1002/art.39473. (anglicky) 
  • Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial. The Lancet. 2017-01-21, roč. 389, čís. 10066, s. 266–275. Dostupné online [cit. 2018-02-10]. ISSN 0140-6736. DOI 10.1016/S0140-6736(16)32537-5. (anglicky) 
  • WEINBLATT, Michael E.; MEASE, Philip; MYSLER, Eduardo. The Efficacy and Safety of Subcutaneous Clazakizumab in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results From a Multinational, Phase IIb, Randomized, Double-Blind, Placebo/Active-Controlled, Dose-Ranging Study. Arthritis & Rheumatology. 2015-10-01, roč. 67, čís. 10, s. 2591–2600. Dostupné online [cit. 2018-02-10]. ISSN 2326-5205. DOI 10.1002/art.39249. (anglicky) 
  • GENOVESE, Mark C.; FLEISCHMANN, Roy; FURST, Daniel. Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study. Annals of the Rheumatic Diseases. 2014-09-01, roč. 73, čís. 9, s. 1607–1615. PMID: 24641941. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2013-204760. PMID 24641941. (anglicky) 
  • BURMESTER, Gerd R.; MCINNES, Iain B.; KREMER, Joel. A randomised phase IIb study of mavrilimumab, a novel GM–CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis. Annals of the Rheumatic Diseases. 2017-06-01, roč. 76, čís. 6, s. 1020–1030. PMID: 28213566. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2016-210624. PMID 28213566. (anglicky) 
  • BEHRENS, Frank; TAK, Paul P.; ØSTERGAARD, Mikkel. MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial. Annals of the Rheumatic Diseases. 2015-06-01, roč. 74, čís. 6, s. 1058–1064. PMID: 24534756. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2013-204816. PMID 24534756. (anglicky) 
  • FISCHER, Jens A. A.; HUEBER, Axel J.; WILSON, Stacy. Combined Inhibition of Tumor Necrosis Factor α and Interleukin-17 As a Therapeutic Opportunity in Rheumatoid Arthritis: Development and Characterization of a Novel Bispecific Antibody. Arthritis & Rheumatology. 2015-01-01, roč. 67, čís. 1, s. 51–62. Dostupné online [cit. 2018-02-10]. ISSN 2326-5205. DOI 10.1002/art.38896. (anglicky) 

doi.org

  • SOKKA, Tuulikki; KAUTIAINEN, Hannu; PINCUS, Theodore. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA Study. Arthritis Research & Therapy. 2010-03-12, roč. 12, s. R42. Dostupné online [cit. 2018-02-10]. ISSN 1478-6354. DOI 10.1186/ar2951. 
  • ZHAO, Xiaoyan; OKEKE, Nwora Lance; SHARPE, Orr. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Research & Therapy. 2008-08-18, roč. 10, s. R94. Dostupné online [cit. 2018-02-10]. ISSN 1478-6354. DOI 10.1186/ar2478. 
  • BOYAPATI, Anita; MSIHID, Jérôme; FIORE, Stefano. Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY. Arthritis Research & Therapy. 2016-10-06, roč. 18, s. 225. Dostupné online [cit. 2018-02-10]. ISSN 1478-6362. DOI 10.1186/s13075-016-1132-9. 
  • BUA, Silvia; DI CESARE MANNELLI, Lorenzo; VULLO, Daniela. Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs–CAIs) for the Treatment of Rheumatoid Arthritis. Journal of Medicinal Chemistry. 2017-02-09, roč. 60, čís. 3, s. 1159–1170. Dostupné online [cit. 2018-02-10]. ISSN 0022-2623. DOI 10.1021/acs.jmedchem.6b01607. 

elsevier.com

linkinghub.elsevier.com

  • CHOI, Hyon K; HERNÁN, Miguel A; SEEGER, John D. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. The Lancet. Roč. 359, čís. 9313, s. 1173–1177. Dostupné online [cit. 2018-02-10]. DOI 10.1016/s0140-6736(02)08213-2. 
  • Redirecting. linkinghub.elsevier.com [online]. [cit. 2018-02-10]. Dostupné online. 
  • Redirecting. linkinghub.elsevier.com [online]. [cit. 2018-02-10]. Dostupné online. 

interna-cz.eu

wp.interna-cz.eu

  • PAVELKA, Karel. Doporučení České revmatologické společnosti pro léčbu revmatoidní artritidy. Česká revmatologie [online]. 2010. Dostupné online. 

jimmunol.org

  • HILL, Jonathan A.; SOUTHWOOD, Scott; SETTE, Alessandro. Cutting Edge: The Conversion of Arginine to Citrulline Allows for a High-Affinity Peptide Interaction with the Rheumatoid Arthritis-Associated HLA-DRB1*0401 MHC Class II Molecule. The Journal of Immunology. 2003-07-15, roč. 171, čís. 2, s. 538–541. PMID: 12847215. Dostupné online [cit. 2018-02-10]. ISSN 0022-1767. DOI 10.4049/jimmunol.171.2.538. PMID 12847215. (anglicky) 
  • GIRBAL-NEUHAUSER, Elisabeth; DURIEUX, Jean-Jacques; ARNAUD, Michel. The Epitopes Targeted by the Rheumatoid Arthritis-Associated Antifilaggrin Autoantibodies are Posttranslationally Generated on Various Sites of (Pro)Filaggrin by Deimination of Arginine Residues. The Journal of Immunology. 1999-01-01, roč. 162, čís. 1, s. 585–594. PMID: 9886436. Dostupné online [cit. 2018-02-10]. ISSN 0022-1767. PMID 9886436. (anglicky) 
  • FRIDMAN, Jordan S.; SCHERLE, Peggy A.; COLLINS, Robert. Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050. The Journal of Immunology. 2010-05-01, roč. 184, čís. 9, s. 5298–5307. PMID: 20363976. Dostupné online [cit. 2018-02-10]. ISSN 0022-1767. DOI 10.4049/jimmunol.0902819. PMID 20363976. (anglicky) 

medicalxpress.com

nature.com

  • OKADA, Yukinori; CONSORTIUM, the RACI; WU, Di. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014/02, roč. 506, čís. 7488, s. 376–381. Dostupné online [cit. 2018-02-10]. ISSN 1476-4687. DOI 10.1038/nature12873. (En) 
  • WRIGHT, Helen L.; MOOTS, Robert J.; EDWARDS, Steven W. The multifactorial role of neutrophils in rheumatoid arthritis. Nature Reviews Rheumatology. 2014/10, roč. 10, čís. 10, s. 593–601. Dostupné online [cit. 2018-02-10]. ISSN 1759-4804. DOI 10.1038/nrrheum.2014.80. (En) 

nih.gov

ncbi.nlm.nih.gov

  • HILL, Jonathan A.; SOUTHWOOD, Scott; SETTE, Alessandro. Cutting Edge: The Conversion of Arginine to Citrulline Allows for a High-Affinity Peptide Interaction with the Rheumatoid Arthritis-Associated HLA-DRB1*0401 MHC Class II Molecule. The Journal of Immunology. 2003-07-15, roč. 171, čís. 2, s. 538–541. PMID: 12847215. Dostupné online [cit. 2018-02-10]. ISSN 0022-1767. DOI 10.4049/jimmunol.171.2.538. PMID 12847215. (anglicky) 
  • KÄLLBERG, Henrik; DING, Bo; PADYUKOV, Leonid. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Annals of the Rheumatic Diseases. 2011-03-01, roč. 70, čís. 3, s. 508–511. PMID: 21149499. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/ard.2009.120899. PMID 21149499. (anglicky) 
  • GHAWI, Husam; CROWSON, Cynthia S.; RAND-WEAVER, Jennifer. A novel measure of socioeconomic status using individual housing data to assess the association of SES with rheumatoid arthritis and its mortality: a population-based case–control study. BMJ Open. 2015-04-01, roč. 5, čís. 4, s. e006469. PMID: 25926142. Dostupné online [cit. 2018-02-10]. ISSN 2044-6055. DOI 10.1136/bmjopen-2014-006469. PMID 25926142. (anglicky) 
  • LU, Bing; HIRAKI, Linda T.; SPARKS, Jeffrey A. Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study. Annals of the Rheumatic Diseases. 2014-11-01, roč. 73, čís. 11, s. 1914–1922. PMID: 25057178. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2014-205459. PMID 25057178. (anglicky) 
  • STOLT, Patrik; YAHYA, Abqariyah; BENGTSSON, Camilla. Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis. Annals of the Rheumatic Diseases. 2010-06-01, roč. 69, čís. 6, s. 1072–1076. PMID: 19966090. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/ard.2009.114694. PMID 19966090. (anglicky) 
  • BROWN, Philip M.; ISAACS, John D. Rheumatoid arthritis: from palliation to remission in two decades. Clinical Medicine. 2014-12-01, roč. 14, čís. Suppl 6, s. s50–s55. PMID: 25468920. Dostupné v archivu pořízeném dne 2018-06-10. ISSN 1470-2118. DOI 10.7861/clinmedicine.14-6-s50. PMID 25468920. (anglicky)  Archivováno 10. 6. 2018 na Wayback Machine.
  • MIRIOVSKY, Benjamin J.; MICHAUD, Kaleb; THIELE, Geoffrey M. Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis. Annals of the Rheumatic Diseases. 2010-07-01, roč. 69, čís. 7, s. 1292–1297. PMID: 20439294. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/ard.2009.122739. PMID 20439294. (anglicky) 
  • BÖHLER, Christoph; RADNER, Helga; SMOLEN, Josef S. Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritis. Annals of the Rheumatic Diseases. 2013-02-01, roč. 72, čís. 2, s. 241–244. PMID: 23087181. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2012-202297. PMID 23087181. (anglicky) 
  • SCHELLEKENS, G A; DE JONG, B A; VAN DEN HOOGEN, F H. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.. Journal of Clinical Investigation. 1998-01-01, roč. 101, čís. 1, s. 273–281. PMID: 9421490 PMCID: PMC508564. Dostupné online [cit. 2018-02-10]. ISSN 0021-9738. PMID 9421490. 
  • GIRBAL-NEUHAUSER, Elisabeth; DURIEUX, Jean-Jacques; ARNAUD, Michel. The Epitopes Targeted by the Rheumatoid Arthritis-Associated Antifilaggrin Autoantibodies are Posttranslationally Generated on Various Sites of (Pro)Filaggrin by Deimination of Arginine Residues. The Journal of Immunology. 1999-01-01, roč. 162, čís. 1, s. 585–594. PMID: 9886436. Dostupné online [cit. 2018-02-10]. ISSN 0022-1767. PMID 9886436. (anglicky) 
  • NELL, V. P. K.; MACHOLD, K. P.; STAMM, T. A. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Annals of the Rheumatic Diseases. 2005-12-01, roč. 64, čís. 12, s. 1731–1736. PMID: 15878904. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/ard.2005.035691. PMID 15878904. (anglicky) 
  • SMOLEN, Josef S.; LANDEWÉ, Robert; BIJLSMA, Johannes. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the Rheumatic Diseases. 2017-06-01, roč. 76, čís. 6, s. 960–977. PMID: 28264816. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2016-210715. PMID 28264816. (anglicky) 
  • SMOLEN, Josef S.; HEIJDE, Désirée van der; MACHOLD, Klaus P. Proposal for a new nomenclature of disease-modifying antirheumatic drugs. Annals of the Rheumatic Diseases. 2014-01-01, roč. 73, čís. 1, s. 3–5. PMID: 24072562. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2013-204317. PMID 24072562. (anglicky) 
  • THOMPSON, Cheryl A. FDA approves tocilizumab to treat rheumatoid arthritis. American Journal of Health-System Pharmacy. 2010-02-15, roč. 67, čís. 4, s. 254–254. PMID: 20133526. Dostupné online [cit. 2018-02-10]. ISSN 1079-2082. DOI 10.2146/news100012. PMID 20133526. (anglicky) 
  • REFF, M. E.; CARNER, K.; CHAMBERS, K. S. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood. 1994-01-15, roč. 83, čís. 2, s. 435–445. PMID: 7506951. Dostupné v archivu pořízeném dne 2017-02-10. ISSN 0006-4971. PMID 7506951. (anglicky) 
  • FRIDMAN, Jordan S.; SCHERLE, Peggy A.; COLLINS, Robert. Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050. The Journal of Immunology. 2010-05-01, roč. 184, čís. 9, s. 5298–5307. PMID: 20363976. Dostupné online [cit. 2018-02-10]. ISSN 0022-1767. DOI 10.4049/jimmunol.0902819. PMID 20363976. (anglicky) 
  • CHANGELIAN, Paul S.; FLANAGAN, Mark E.; BALL, Douglas J. Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor. Science. 2003-10-31, roč. 302, čís. 5646, s. 875–878. PMID: 14593182. Dostupné online [cit. 2018-02-10]. ISSN 0036-8075. DOI 10.1126/science.1087061. PMID 14593182. (anglicky) 
  • GENOVESE, Mark C.; FLEISCHMANN, Roy; FURST, Daniel. Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study. Annals of the Rheumatic Diseases. 2014-09-01, roč. 73, čís. 9, s. 1607–1615. PMID: 24641941. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2013-204760. PMID 24641941. (anglicky) 
  • BURMESTER, Gerd R.; MCINNES, Iain B.; KREMER, Joel. A randomised phase IIb study of mavrilimumab, a novel GM–CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis. Annals of the Rheumatic Diseases. 2017-06-01, roč. 76, čís. 6, s. 1020–1030. PMID: 28213566. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2016-210624. PMID 28213566. (anglicky) 
  • BEHRENS, Frank; TAK, Paul P.; ØSTERGAARD, Mikkel. MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial. Annals of the Rheumatic Diseases. 2015-06-01, roč. 74, čís. 6, s. 1058–1064. PMID: 24534756. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2013-204816. PMID 24534756. (anglicky) 

oup.com

academic.oup.com

  • ZAMORA-LEGOFF, Jorge A.; KRAUSE, Megan L.; CROWSON, Cynthia S. Patterns of interstitial lung disease and mortality in rheumatoid arthritis. Rheumatology. 2017-03-01, roč. 56, čís. 3, s. 344–350. Dostupné online [cit. 2018-02-10]. ISSN 1462-0324. DOI 10.1093/rheumatology/kew391. (anglicky) 
  • MAXWELL, James R.; GOWERS, Isobel R.; MOORE, David J. Alcohol consumption is inversely associated with risk and severity of rheumatoid arthritis. Rheumatology. 2010-11-01, roč. 49, čís. 11, s. 2140–2146. Dostupné online [cit. 2018-02-10]. ISSN 1462-0324. DOI 10.1093/rheumatology/keq202. (anglicky) 
  • NELL, V. P. K.; MACHOLD, K. P.; EBERL, G. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology. 2004-07-01, roč. 43, čís. 7, s. 906–914. Dostupné online [cit. 2018-02-10]. ISSN 1462-0324. DOI 10.1093/rheumatology/keh199. (anglicky) 

proquest.com

search.proquest.com

  • SUZUKI, Akari. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis - ProQuest. search.proquest.com [online]. [cit. 2018-02-10]. Dostupné online. 

sciencedirect.com

  • Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial. The Lancet. 2015-08-08, roč. 386, čís. 9993, s. 552–561. Dostupné online [cit. 2018-02-10]. ISSN 0140-6736. DOI 10.1016/S0140-6736(14)62113-9. (anglicky) 
  • Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial. The Lancet. 2017-01-21, roč. 389, čís. 10066, s. 266–275. Dostupné online [cit. 2018-02-10]. ISSN 0140-6736. DOI 10.1016/S0140-6736(16)32537-5. (anglicky) 

sciencemag.org

science.sciencemag.org

smj.org.sa

  • HARIFI, Ghita; SIBILIA, Jean. Pathogenic role of platelets in rheumatoid arthritis and systemic autoimmune diseases. Perspectives and therapeutic aspects. Saudi Medical Journal. 2016-04-01, roč. 37, čís. 4, s. 354–360. Dostupné online [cit. 2018-02-10]. ISSN 1658-3175. (anglicky) [nedostupný zdroj]

springer.com

link.springer.com

  • HOEK, J. van den; BOSHUIZEN, H. C.; ROORDA, L. D. Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study. Rheumatology International. 2017-04-01, roč. 37, čís. 4, s. 487–493. Dostupné online [cit. 2018-02-10]. ISSN 0172-8172. DOI 10.1007/s00296-016-3638-5. (anglicky) 
  • ZLATKOVIĆ-ŠVENDA, Mirjana I.; STOJANOVIĆ, Roksanda M.; ŠIPETIĆ-GRUJIČIĆ, Sandra B. Prevalence of rheumatoid arthritis in Serbia. Rheumatology International. 2014-05-01, roč. 34, čís. 5, s. 649–658. Dostupné online [cit. 2018-02-10]. ISSN 0172-8172. DOI 10.1007/s00296-013-2897-7. (anglicky) 

tandfonline.com

web.archive.org

wiley.com

onlinelibrary.wiley.com

  • NIELEN, Markus M. J.; VAN SCHAARDENBURG, Dirkjan; REESINK, Henk W. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis & Rheumatism. 2004-02-01, roč. 50, čís. 2, s. 380–386. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.20018. (anglicky) 
  • PUENTE, Antonio Del; KNOWLER, William C.; PETTITT, David J. The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study. Arthritis & Rheumatism. 1988-10-01, roč. 31, čís. 10, s. 1239–1244. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.1780311004. (anglicky) 
  • AVIÑA-ZUBIETA, J. Antonio; CHOI, Hyon K.; SADATSAFAVI, Mohsen. Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis Care & Research. 2008-12-15, roč. 59, čís. 12, s. 1690–1697. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.24092. (anglicky) 
  • PINCUS, Theodore; CALLAHAN, Leigh F.; SALE, William G. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis & Rheumatism. 1984-08-01, roč. 27, čís. 8, s. 864–872. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.1780270805. (anglicky) 
  • GREGERSEN, Peter K.; SILVER, Jack; WINCHESTER, Robert J. The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis & Rheumatism. 1987-11-01, roč. 30, čís. 11, s. 1205–1213. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.1780301102. (anglicky) 
  • REVIRON, Denis; PERDRIGER, Aleth; TOUSSIROT, Eric. Influence of shared epitope–negative HLA–DRB1 alleles on genetic susceptibility to rheumatoid arthritis. Arthritis & Rheumatism. 2001-03-01, roč. 44, čís. 3, s. 535–540. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/1529-0131(200103)44:3%3C535::aid-anr101%3E3.0.co;2-z. (anglicky) 
  • LU, Bing; SOLOMON, Daniel H.; COSTENBADER, Karen H. Alcohol Consumption and Risk of Incident Rheumatoid Arthritis in Women: A Prospective Study. Arthritis & Rheumatology. 2014-08-01, roč. 66, čís. 8, s. 1998–2005. Dostupné online [cit. 2018-02-10]. ISSN 2326-5205. DOI 10.1002/art.38634. (anglicky) 
  • WEGNER, Natalia; WAIT, Robin; SROKA, Aneta. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: Implications for autoimmunity in rheumatoid arthritis. Arthritis & Rheumatism. 2010-09-01, roč. 62, čís. 9, s. 2662–2672. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.27552. (anglicky) 
  • SCHER, Jose U.; LITTMAN, Dan R.; ABRAMSON, Steven B. Review: Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases. Arthritis & Rheumatology. 2016-01-01, roč. 68, čís. 1, s. 35–45. Dostupné online [cit. 2018-02-10]. ISSN 2326-5205. DOI 10.1002/art.39259. (anglicky) 
  • KIRKHAM, Bruce W.; LASSERE, Marissa N.; EDMONDS, John P. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: A two-year prospective study (the DAMAGE study cohort). Arthritis & Rheumatism. 2006-04-01, roč. 54, čís. 4, s. 1122–1131. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.21749. (anglicky) 
  • VAN HAMBURG, J. P.; ASMAWIDJAJA, P. S.; DAVELAAR, N. Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis & Rheumatism. 2011-01-01, roč. 63, čís. 1, s. 73–83. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.30093. (anglicky) 
  • KROOT, Eric-Jan J. A.; DE JONG, Ben A. W.; VAN LEEUWEN, Miek A. The prognostic value of anti–cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis & Rheumatism. 2000-08-01, roč. 43, čís. 8, s. 1831–1835. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/1529-0131(200008)43:8%3C1831::aid-anr19%3E3.0.co;2-6. (anglicky) 
  • RANTAPÄÄ-DAHLQVIST, Solbritt; DE JONG, Ben A. W.; BERGLIN, Ewa. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis & Rheumatism. 2003-10-01, roč. 48, čís. 10, s. 2741–2749. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.11223. (anglicky) 
  • ALETAHA, Daniel; NEOGI, Tuhina; SILMAN, Alan J. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis & Rheumatism. 2010-09-01, roč. 62, čís. 9, s. 2569–2581. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.27584. (anglicky) 
  • VAN DER LINDEN, Michael P. M.; LE CESSIE, Saskia; RAZA, Karim. Long-term impact of delay in assessment of patients with early arthritis. Arthritis & Rheumatism. 2010-12-01, roč. 62, čís. 12, s. 3537–3546. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.27692. (anglicky) 
  • ANDERSON, Jaclyn; CAPLAN, Liron; YAZDANY, Jinoos. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care & Research. 2012-05-01, roč. 64, čís. 5, s. 640–647. Dostupné online [cit. 2018-02-10]. ISSN 2151-4658. DOI 10.1002/acr.21649. (anglicky) 
  • MAINI, Ravinder N.; BREEDVELD, Ferdinand C.; KALDEN, Joachim R. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis & Rheumatism. 1998-09-01, roč. 41, čís. 9, s. 1552–1563. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/1529-0131(199809)41:9%3C1552::aid-art5%3E3.0.co;2-w. (anglicky) 
  • BONELLI, M.; FERNER, E.; GÖSCHL, L. Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis. Arthritis & Rheumatism. 2013-03-01, roč. 65, čís. 3, s. 599–607. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.37787. (anglicky) 
  • KREMER, Joel M.; DOUGADOS, Maxime; EMERY, Paul. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial. Arthritis & Rheumatism. 2005-08-01, roč. 52, čís. 8, s. 2263–2271. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.21201. (anglicky) 
  • PATAKAS, Agapitos; JI, Rui-Ru; WEIR, William. Abatacept Inhibition of T Cell Priming in Mice by Induction of a Unique Transcriptional Profile That Reduces Their Ability to Activate Antigen-Presenting Cells. Arthritis & Rheumatology. 2016-03-01, roč. 68, čís. 3, s. 627–638. Dostupné online [cit. 2018-02-10]. ISSN 2326-5205. DOI 10.1002/art.39470. (anglicky) 
  • COHEN, Stanley B.; EMERY, Paul; GREENWALD, Maria W. Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis & Rheumatism. 2006-09-01, roč. 54, čís. 9, s. 2793–2806. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.22025. (anglicky) 
  • PAPP, K.a.; MENTER, M.a.; RAMAN, M. A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis. British Journal of Dermatology. 2016-06-01, roč. 174, čís. 6, s. 1266–1276. Dostupné online [cit. 2018-02-10]. ISSN 1365-2133. DOI 10.1111/bjd.14403. (anglicky) 
  • GENOVESE, Mark C.; VAN VOLLENHOVEN, Ronald F.; PACHECO-TENA, César. VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis. Arthritis & Rheumatology. 2016-01-01, roč. 68, čís. 1, s. 46–55. Dostupné online [cit. 2018-02-10]. ISSN 2326-5205. DOI 10.1002/art.39473. (anglicky) 
  • WEINBLATT, Michael E.; MEASE, Philip; MYSLER, Eduardo. The Efficacy and Safety of Subcutaneous Clazakizumab in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results From a Multinational, Phase IIb, Randomized, Double-Blind, Placebo/Active-Controlled, Dose-Ranging Study. Arthritis & Rheumatology. 2015-10-01, roč. 67, čís. 10, s. 2591–2600. Dostupné online [cit. 2018-02-10]. ISSN 2326-5205. DOI 10.1002/art.39249. (anglicky) 
  • FISCHER, Jens A. A.; HUEBER, Axel J.; WILSON, Stacy. Combined Inhibition of Tumor Necrosis Factor α and Interleukin-17 As a Therapeutic Opportunity in Rheumatoid Arthritis: Development and Characterization of a Novel Bispecific Antibody. Arthritis & Rheumatology. 2015-01-01, roč. 67, čís. 1, s. 51–62. Dostupné online [cit. 2018-02-10]. ISSN 2326-5205. DOI 10.1002/art.38896. (anglicky) 

worldcat.org

  • NIELEN, Markus M. J.; VAN SCHAARDENBURG, Dirkjan; REESINK, Henk W. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis & Rheumatism. 2004-02-01, roč. 50, čís. 2, s. 380–386. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.20018. (anglicky) 
  • PUENTE, Antonio Del; KNOWLER, William C.; PETTITT, David J. The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study. Arthritis & Rheumatism. 1988-10-01, roč. 31, čís. 10, s. 1239–1244. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.1780311004. (anglicky) 
  • HOEK, J. van den; BOSHUIZEN, H. C.; ROORDA, L. D. Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study. Rheumatology International. 2017-04-01, roč. 37, čís. 4, s. 487–493. Dostupné online [cit. 2018-02-10]. ISSN 0172-8172. DOI 10.1007/s00296-016-3638-5. (anglicky) 
  • ZAMORA-LEGOFF, Jorge A.; KRAUSE, Megan L.; CROWSON, Cynthia S. Patterns of interstitial lung disease and mortality in rheumatoid arthritis. Rheumatology. 2017-03-01, roč. 56, čís. 3, s. 344–350. Dostupné online [cit. 2018-02-10]. ISSN 1462-0324. DOI 10.1093/rheumatology/kew391. (anglicky) 
  • AVIÑA-ZUBIETA, J. Antonio; CHOI, Hyon K.; SADATSAFAVI, Mohsen. Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis Care & Research. 2008-12-15, roč. 59, čís. 12, s. 1690–1697. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.24092. (anglicky) 
  • ZLATKOVIĆ-ŠVENDA, Mirjana I.; STOJANOVIĆ, Roksanda M.; ŠIPETIĆ-GRUJIČIĆ, Sandra B. Prevalence of rheumatoid arthritis in Serbia. Rheumatology International. 2014-05-01, roč. 34, čís. 5, s. 649–658. Dostupné online [cit. 2018-02-10]. ISSN 0172-8172. DOI 10.1007/s00296-013-2897-7. (anglicky) 
  • PINCUS, Theodore; CALLAHAN, Leigh F.; SALE, William G. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis & Rheumatism. 1984-08-01, roč. 27, čís. 8, s. 864–872. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.1780270805. (anglicky) 
  • SOKKA, Tuulikki; KAUTIAINEN, Hannu; PINCUS, Theodore. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA Study. Arthritis Research & Therapy. 2010-03-12, roč. 12, s. R42. Dostupné online [cit. 2018-02-10]. ISSN 1478-6354. DOI 10.1186/ar2951. 
  • OKADA, Yukinori; CONSORTIUM, the RACI; WU, Di. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014/02, roč. 506, čís. 7488, s. 376–381. Dostupné online [cit. 2018-02-10]. ISSN 1476-4687. DOI 10.1038/nature12873. (En) 
  • GREGERSEN, Peter K.; SILVER, Jack; WINCHESTER, Robert J. The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis & Rheumatism. 1987-11-01, roč. 30, čís. 11, s. 1205–1213. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.1780301102. (anglicky) 
  • HILL, Jonathan A.; SOUTHWOOD, Scott; SETTE, Alessandro. Cutting Edge: The Conversion of Arginine to Citrulline Allows for a High-Affinity Peptide Interaction with the Rheumatoid Arthritis-Associated HLA-DRB1*0401 MHC Class II Molecule. The Journal of Immunology. 2003-07-15, roč. 171, čís. 2, s. 538–541. PMID: 12847215. Dostupné online [cit. 2018-02-10]. ISSN 0022-1767. DOI 10.4049/jimmunol.171.2.538. PMID 12847215. (anglicky) 
  • REVIRON, Denis; PERDRIGER, Aleth; TOUSSIROT, Eric. Influence of shared epitope–negative HLA–DRB1 alleles on genetic susceptibility to rheumatoid arthritis. Arthritis & Rheumatism. 2001-03-01, roč. 44, čís. 3, s. 535–540. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/1529-0131(200103)44:3%3C535::aid-anr101%3E3.0.co;2-z. (anglicky) 
  • KÄLLBERG, Henrik; DING, Bo; PADYUKOV, Leonid. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Annals of the Rheumatic Diseases. 2011-03-01, roč. 70, čís. 3, s. 508–511. PMID: 21149499. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/ard.2009.120899. PMID 21149499. (anglicky) 
  • GHAWI, Husam; CROWSON, Cynthia S.; RAND-WEAVER, Jennifer. A novel measure of socioeconomic status using individual housing data to assess the association of SES with rheumatoid arthritis and its mortality: a population-based case–control study. BMJ Open. 2015-04-01, roč. 5, čís. 4, s. e006469. PMID: 25926142. Dostupné online [cit. 2018-02-10]. ISSN 2044-6055. DOI 10.1136/bmjopen-2014-006469. PMID 25926142. (anglicky) 
  • LU, Bing; HIRAKI, Linda T.; SPARKS, Jeffrey A. Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study. Annals of the Rheumatic Diseases. 2014-11-01, roč. 73, čís. 11, s. 1914–1922. PMID: 25057178. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2014-205459. PMID 25057178. (anglicky) 
  • STOLT, Patrik; YAHYA, Abqariyah; BENGTSSON, Camilla. Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis. Annals of the Rheumatic Diseases. 2010-06-01, roč. 69, čís. 6, s. 1072–1076. PMID: 19966090. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/ard.2009.114694. PMID 19966090. (anglicky) 
  • LU, Bing; SOLOMON, Daniel H.; COSTENBADER, Karen H. Alcohol Consumption and Risk of Incident Rheumatoid Arthritis in Women: A Prospective Study. Arthritis & Rheumatology. 2014-08-01, roč. 66, čís. 8, s. 1998–2005. Dostupné online [cit. 2018-02-10]. ISSN 2326-5205. DOI 10.1002/art.38634. (anglicky) 
  • MAXWELL, James R.; GOWERS, Isobel R.; MOORE, David J. Alcohol consumption is inversely associated with risk and severity of rheumatoid arthritis. Rheumatology. 2010-11-01, roč. 49, čís. 11, s. 2140–2146. Dostupné online [cit. 2018-02-10]. ISSN 1462-0324. DOI 10.1093/rheumatology/keq202. (anglicky) 
  • WEGNER, Natalia; WAIT, Robin; SROKA, Aneta. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: Implications for autoimmunity in rheumatoid arthritis. Arthritis & Rheumatism. 2010-09-01, roč. 62, čís. 9, s. 2662–2672. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.27552. (anglicky) 
  • SCHER, Jose U.; LITTMAN, Dan R.; ABRAMSON, Steven B. Review: Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases. Arthritis & Rheumatology. 2016-01-01, roč. 68, čís. 1, s. 35–45. Dostupné online [cit. 2018-02-10]. ISSN 2326-5205. DOI 10.1002/art.39259. (anglicky) 
  • BROWN, Philip M.; ISAACS, John D. Rheumatoid arthritis: from palliation to remission in two decades. Clinical Medicine. 2014-12-01, roč. 14, čís. Suppl 6, s. s50–s55. PMID: 25468920. Dostupné v archivu pořízeném dne 2018-06-10. ISSN 1470-2118. DOI 10.7861/clinmedicine.14-6-s50. PMID 25468920. (anglicky)  Archivováno 10. 6. 2018 na Wayback Machine.
  • KIRKHAM, Bruce W.; LASSERE, Marissa N.; EDMONDS, John P. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: A two-year prospective study (the DAMAGE study cohort). Arthritis & Rheumatism. 2006-04-01, roč. 54, čís. 4, s. 1122–1131. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.21749. (anglicky) 
  • VAN HAMBURG, J. P.; ASMAWIDJAJA, P. S.; DAVELAAR, N. Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis & Rheumatism. 2011-01-01, roč. 63, čís. 1, s. 73–83. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.30093. (anglicky) 
  • HARIFI, Ghita; SIBILIA, Jean. Pathogenic role of platelets in rheumatoid arthritis and systemic autoimmune diseases. Perspectives and therapeutic aspects. Saudi Medical Journal. 2016-04-01, roč. 37, čís. 4, s. 354–360. Dostupné online [cit. 2018-02-10]. ISSN 1658-3175. (anglicky) [nedostupný zdroj]
  • WRIGHT, Helen L.; MOOTS, Robert J.; EDWARDS, Steven W. The multifactorial role of neutrophils in rheumatoid arthritis. Nature Reviews Rheumatology. 2014/10, roč. 10, čís. 10, s. 593–601. Dostupné online [cit. 2018-02-10]. ISSN 1759-4804. DOI 10.1038/nrrheum.2014.80. (En) 
  • ZHAO, Xiaoyan; OKEKE, Nwora Lance; SHARPE, Orr. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Research & Therapy. 2008-08-18, roč. 10, s. R94. Dostupné online [cit. 2018-02-10]. ISSN 1478-6354. DOI 10.1186/ar2478. 
  • MIRIOVSKY, Benjamin J.; MICHAUD, Kaleb; THIELE, Geoffrey M. Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis. Annals of the Rheumatic Diseases. 2010-07-01, roč. 69, čís. 7, s. 1292–1297. PMID: 20439294. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/ard.2009.122739. PMID 20439294. (anglicky) 
  • BÖHLER, Christoph; RADNER, Helga; SMOLEN, Josef S. Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritis. Annals of the Rheumatic Diseases. 2013-02-01, roč. 72, čís. 2, s. 241–244. PMID: 23087181. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2012-202297. PMID 23087181. (anglicky) 
  • SCHELLEKENS, G A; DE JONG, B A; VAN DEN HOOGEN, F H. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.. Journal of Clinical Investigation. 1998-01-01, roč. 101, čís. 1, s. 273–281. PMID: 9421490 PMCID: PMC508564. Dostupné online [cit. 2018-02-10]. ISSN 0021-9738. PMID 9421490. 
  • GIRBAL-NEUHAUSER, Elisabeth; DURIEUX, Jean-Jacques; ARNAUD, Michel. The Epitopes Targeted by the Rheumatoid Arthritis-Associated Antifilaggrin Autoantibodies are Posttranslationally Generated on Various Sites of (Pro)Filaggrin by Deimination of Arginine Residues. The Journal of Immunology. 1999-01-01, roč. 162, čís. 1, s. 585–594. PMID: 9886436. Dostupné online [cit. 2018-02-10]. ISSN 0022-1767. PMID 9886436. (anglicky) 
  • KROOT, Eric-Jan J. A.; DE JONG, Ben A. W.; VAN LEEUWEN, Miek A. The prognostic value of anti–cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis & Rheumatism. 2000-08-01, roč. 43, čís. 8, s. 1831–1835. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/1529-0131(200008)43:8%3C1831::aid-anr19%3E3.0.co;2-6. (anglicky) 
  • NELL, V. P. K.; MACHOLD, K. P.; EBERL, G. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology. 2004-07-01, roč. 43, čís. 7, s. 906–914. Dostupné online [cit. 2018-02-10]. ISSN 1462-0324. DOI 10.1093/rheumatology/keh199. (anglicky) 
  • NELL, V. P. K.; MACHOLD, K. P.; STAMM, T. A. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Annals of the Rheumatic Diseases. 2005-12-01, roč. 64, čís. 12, s. 1731–1736. PMID: 15878904. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/ard.2005.035691. PMID 15878904. (anglicky) 
  • RANTAPÄÄ-DAHLQVIST, Solbritt; DE JONG, Ben A. W.; BERGLIN, Ewa. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis & Rheumatism. 2003-10-01, roč. 48, čís. 10, s. 2741–2749. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.11223. (anglicky) 
  • ALETAHA, Daniel; NEOGI, Tuhina; SILMAN, Alan J. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis & Rheumatism. 2010-09-01, roč. 62, čís. 9, s. 2569–2581. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.27584. (anglicky) 
  • SMOLEN, Josef S.; LANDEWÉ, Robert; BIJLSMA, Johannes. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the Rheumatic Diseases. 2017-06-01, roč. 76, čís. 6, s. 960–977. PMID: 28264816. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2016-210715. PMID 28264816. (anglicky) 
  • VAN DER LINDEN, Michael P. M.; LE CESSIE, Saskia; RAZA, Karim. Long-term impact of delay in assessment of patients with early arthritis. Arthritis & Rheumatism. 2010-12-01, roč. 62, čís. 12, s. 3537–3546. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.27692. (anglicky) 
  • SMOLEN, Josef S.; HEIJDE, Désirée van der; MACHOLD, Klaus P. Proposal for a new nomenclature of disease-modifying antirheumatic drugs. Annals of the Rheumatic Diseases. 2014-01-01, roč. 73, čís. 1, s. 3–5. PMID: 24072562. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2013-204317. PMID 24072562. (anglicky) 
  • ANDERSON, Jaclyn; CAPLAN, Liron; YAZDANY, Jinoos. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care & Research. 2012-05-01, roč. 64, čís. 5, s. 640–647. Dostupné online [cit. 2018-02-10]. ISSN 2151-4658. DOI 10.1002/acr.21649. (anglicky) 
  • MAINI, Ravinder N.; BREEDVELD, Ferdinand C.; KALDEN, Joachim R. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis & Rheumatism. 1998-09-01, roč. 41, čís. 9, s. 1552–1563. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/1529-0131(199809)41:9%3C1552::aid-art5%3E3.0.co;2-w. (anglicky) 
  • THOMPSON, Cheryl A. FDA approves tocilizumab to treat rheumatoid arthritis. American Journal of Health-System Pharmacy. 2010-02-15, roč. 67, čís. 4, s. 254–254. PMID: 20133526. Dostupné online [cit. 2018-02-10]. ISSN 1079-2082. DOI 10.2146/news100012. PMID 20133526. (anglicky) 
  • BOYAPATI, Anita; MSIHID, Jérôme; FIORE, Stefano. Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY. Arthritis Research & Therapy. 2016-10-06, roč. 18, s. 225. Dostupné online [cit. 2018-02-10]. ISSN 1478-6362. DOI 10.1186/s13075-016-1132-9. 
  • BONELLI, M.; FERNER, E.; GÖSCHL, L. Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis. Arthritis & Rheumatism. 2013-03-01, roč. 65, čís. 3, s. 599–607. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.37787. (anglicky) 
  • KREMER, Joel M.; DOUGADOS, Maxime; EMERY, Paul. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial. Arthritis & Rheumatism. 2005-08-01, roč. 52, čís. 8, s. 2263–2271. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.21201. (anglicky) 
  • PATAKAS, Agapitos; JI, Rui-Ru; WEIR, William. Abatacept Inhibition of T Cell Priming in Mice by Induction of a Unique Transcriptional Profile That Reduces Their Ability to Activate Antigen-Presenting Cells. Arthritis & Rheumatology. 2016-03-01, roč. 68, čís. 3, s. 627–638. Dostupné online [cit. 2018-02-10]. ISSN 2326-5205. DOI 10.1002/art.39470. (anglicky) 
  • COHEN, Stanley B.; EMERY, Paul; GREENWALD, Maria W. Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis & Rheumatism. 2006-09-01, roč. 54, čís. 9, s. 2793–2806. Dostupné online [cit. 2018-02-10]. ISSN 1529-0131. DOI 10.1002/art.22025. (anglicky) 
  • REFF, M. E.; CARNER, K.; CHAMBERS, K. S. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood. 1994-01-15, roč. 83, čís. 2, s. 435–445. PMID: 7506951. Dostupné v archivu pořízeném dne 2017-02-10. ISSN 0006-4971. PMID 7506951. (anglicky) 
  • SKINGLE, Diana. Biosimilars: what do patients need to consider?. RMD Open. 2015-09-01, roč. 1, čís. 1, s. e000141. Dostupné online [cit. 2018-02-10]. ISSN 2056-5933. DOI 10.1136/rmdopen-2015-000141. (anglicky) 
  • FRIDMAN, Jordan S.; SCHERLE, Peggy A.; COLLINS, Robert. Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050. The Journal of Immunology. 2010-05-01, roč. 184, čís. 9, s. 5298–5307. PMID: 20363976. Dostupné online [cit. 2018-02-10]. ISSN 0022-1767. DOI 10.4049/jimmunol.0902819. PMID 20363976. (anglicky) 
  • PAPP, K.a.; MENTER, M.a.; RAMAN, M. A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis. British Journal of Dermatology. 2016-06-01, roč. 174, čís. 6, s. 1266–1276. Dostupné online [cit. 2018-02-10]. ISSN 1365-2133. DOI 10.1111/bjd.14403. (anglicky) 
  • CHANGELIAN, Paul S.; FLANAGAN, Mark E.; BALL, Douglas J. Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor. Science. 2003-10-31, roč. 302, čís. 5646, s. 875–878. PMID: 14593182. Dostupné online [cit. 2018-02-10]. ISSN 0036-8075. DOI 10.1126/science.1087061. PMID 14593182. (anglicky) 
  • Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial. The Lancet. 2015-08-08, roč. 386, čís. 9993, s. 552–561. Dostupné online [cit. 2018-02-10]. ISSN 0140-6736. DOI 10.1016/S0140-6736(14)62113-9. (anglicky) 
  • BUA, Silvia; DI CESARE MANNELLI, Lorenzo; VULLO, Daniela. Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs–CAIs) for the Treatment of Rheumatoid Arthritis. Journal of Medicinal Chemistry. 2017-02-09, roč. 60, čís. 3, s. 1159–1170. Dostupné online [cit. 2018-02-10]. ISSN 0022-2623. DOI 10.1021/acs.jmedchem.6b01607. 
  • GENOVESE, Mark C.; VAN VOLLENHOVEN, Ronald F.; PACHECO-TENA, César. VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis. Arthritis & Rheumatology. 2016-01-01, roč. 68, čís. 1, s. 46–55. Dostupné online [cit. 2018-02-10]. ISSN 2326-5205. DOI 10.1002/art.39473. (anglicky) 
  • Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial. The Lancet. 2017-01-21, roč. 389, čís. 10066, s. 266–275. Dostupné online [cit. 2018-02-10]. ISSN 0140-6736. DOI 10.1016/S0140-6736(16)32537-5. (anglicky) 
  • WEINBLATT, Michael E.; MEASE, Philip; MYSLER, Eduardo. The Efficacy and Safety of Subcutaneous Clazakizumab in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results From a Multinational, Phase IIb, Randomized, Double-Blind, Placebo/Active-Controlled, Dose-Ranging Study. Arthritis & Rheumatology. 2015-10-01, roč. 67, čís. 10, s. 2591–2600. Dostupné online [cit. 2018-02-10]. ISSN 2326-5205. DOI 10.1002/art.39249. (anglicky) 
  • GENOVESE, Mark C.; FLEISCHMANN, Roy; FURST, Daniel. Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study. Annals of the Rheumatic Diseases. 2014-09-01, roč. 73, čís. 9, s. 1607–1615. PMID: 24641941. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2013-204760. PMID 24641941. (anglicky) 
  • BURMESTER, Gerd R.; MCINNES, Iain B.; KREMER, Joel. A randomised phase IIb study of mavrilimumab, a novel GM–CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis. Annals of the Rheumatic Diseases. 2017-06-01, roč. 76, čís. 6, s. 1020–1030. PMID: 28213566. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2016-210624. PMID 28213566. (anglicky) 
  • BEHRENS, Frank; TAK, Paul P.; ØSTERGAARD, Mikkel. MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial. Annals of the Rheumatic Diseases. 2015-06-01, roč. 74, čís. 6, s. 1058–1064. PMID: 24534756. Dostupné online [cit. 2018-02-10]. ISSN 0003-4967. DOI 10.1136/annrheumdis-2013-204816. PMID 24534756. (anglicky) 
  • FISCHER, Jens A. A.; HUEBER, Axel J.; WILSON, Stacy. Combined Inhibition of Tumor Necrosis Factor α and Interleukin-17 As a Therapeutic Opportunity in Rheumatoid Arthritis: Development and Characterization of a Novel Bispecific Antibody. Arthritis & Rheumatology. 2015-01-01, roč. 67, čís. 1, s. 51–62. Dostupné online [cit. 2018-02-10]. ISSN 2326-5205. DOI 10.1002/art.38896. (anglicky)